ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
ID Genomics has raised $300K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
ID Genomics's investors include National Institutes of Health.
ID Genomics is headquartered in Seattle, United States.
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
ID Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ID Genomics — Funding & Investors." VCBacked, August 24, 2021, https://www.vcbacked.co/company/id-genomics. Accessed July 20, 2026.
VCBacked. (2021). ID Genomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/id-genomics
{{cite web |title=ID Genomics — Funding & Investors |url=https://www.vcbacked.co/company/id-genomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated